EARNINGS: Gem Diamonds revenue down; Brooks Macdonald outflows ease
(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More
Price | 14.25p on 16-09-2025 | at 18:10:05
---|---|
Change | -1.25p -8.2% |
Buy | 14.50p |
Sell | 14.00p |
Last Trade: | Sell 357.00 at 14.00p |
Day's Volume: | 2,389,901 |
Last Close: | 14.00p |
Open: | 15.25p |
ISIN: | GB00BDQZGK16 |
Day's Range | 14.00p - 14.00p |
52wk Range: | 3.20p - 18.15p |
Market Capitalisation: | £15.91m |
VWAP: | 15.06973p |
Shares in Issue: | 113.66m |
Sector: Health Care and Related Services
Listed In: FTSE AIM All-Share,
Fusion Antibodies (FAB) Latest Trades |
||||
Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
---|---|---|---|---|
Sell* | 357 | 14.00p | Uncrossing Trade |
16:35:23 - 16-Sep-25 |
Buy* | 4 | 14.495p | Ordinary |
16:29:49 - 16-Sep-25 |
Buy* | 4 | 14.495p | Ordinary |
16:29:28 - 16-Sep-25 |
Buy* | 4 | 14.495p | Ordinary |
16:29:08 - 16-Sep-25 |
Buy* | 2,000 | 14.495p | Ordinary |
16:28:15 - 16-Sep-25 |
Buy* | 4 | 14.50p | Ordinary |
16:19:23 - 16-Sep-25 |
Buy* | 295 | 14.37p | Ordinary |
16:11:07 - 16-Sep-25 |
Buy* | 20,000 | 14.425p | Ordinary |
16:10:33 - 16-Sep-25 |
Buy* | 412 | 14.50p | Ordinary |
16:08:53 - 16-Sep-25 |
Buy* | 2,220 | 14.50p | Ordinary |
16:01:27 - 16-Sep-25 |
Fusion Antibodies (FAB) Regulatory News |
||
Date | Source | Headline |
---|---|---|
8th Sep 2025 7:00 am | RNS-R | Belfast investor presentation |
4th Sep 2025 7:00 am | RNS | Final Results |
28th Aug 2025 7:00 am | RNS | Contract Win |
27th Aug 2025 7:00 am | RNS | Contract wins with existing client |
26th Aug 2025 7:00 am | RNS-R | Investor presentations |
5th Aug 2025 7:00 am | RNS | Grant of U.S. Patent for OptiMAL |
24th Jul 2025 10:56 am | RNS | Issue Notification: US Patent Update |
11th Jul 2025 7:00 am | RNS | Director/PDMR Shareholding |
2nd Jun 2025 7:00 am | RNS | Total Voting Rights |
22nd May 2025 2:33 pm | RNS | Update on U.S. Patent for OptiMAL® |